The Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit is an NGS-based targeted sequencing assay to detect CNVs, SNVs and indels in 31 thyroid and lung cancer-implicated genes.
The kit covers entire targeted exons while maintaining high coverage uniformity (> 95%) and on-target reads (99.9%). When used alongside the RNA-based FusionPlex® CTL Kit, fusions, SNVs, CNVs and expression profiles can be analyzed from a single low-input FFPE sample. Archer Analysis software allow the analysis and interpretation of the data.
Archer® Solid Tumor assays provide a targeted sequencing approach to detect various driver mutation types in solid tumors. This approach combines FusionPlex®, VariantPlex® and Reveal ctDNA™ kits to characterize gene fusions, expression, CNVs and other variants from a single, low-input FFPE sample and liquid biopsy.
|VariantPlex® CTL Kit, for Illumina®- 8 reactions||AB0077|
|VariantPlex®CTL Starter Kit, for Illumina® - 16 reactions||AB0079|
|VariantPlex®CTL Kit, for Illumina® - 48 reactions||AB0081|